2017 Survivorship Public

Mohammad Abu Zaid, MD, during Abstract 102: Metabolic syndrome (MetS) after platinum-based chemotherapy (CHEM): A multicenter study of North American testicular cancer survivors (TCS)

San Diego, CA - 2017 Cancer Survivorship Symposium - Mohammad Abu Zaid, MD, during Abstract 102: Metabolic syndrome (MetS) after platinum-based chemotherapy (CHEM): A multicenter study of North American testicular cancer survivors (TCS) at the 2017 Cancer Survivorship Symposium here today, Friday, January 27, 2017. The conference is a collaboration among the American Academy of Family Physicians, the American College of Physicians, and the American Society of Clinical Oncology that provides information about survivorship issues that both primary care physicians and oncologists are faced with throughout the cancer care continuum. Photo by © ASCO/Todd Buchanan 2017